Latest Breaking News On - ப்ரைஸஸ் கட்டுப்பாடு - Page 1 : comparemela.com

India s Remdesivir production capacity increased to 122 49 lakh vials per month in June: Government | India News

India s Remdesivir production capacity increased to 122 49 lakh vials per month in June: Government | India News
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Rajya sabhaMansukh mandaviyaNational pharmaceuticals pricing authorityCentral drugs standard control organisationDrugs controller generalActive pharmaceutical ingredientBuffer stock managementPrices controlராஜ்யா சபாமன்சுக் மண்டவியாதேசிய மருந்துகள் ப்ரைஸிஂக் அதிகாரம்மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந்மருந்துகள் கட்டுப்படுத்தி ஜநரல்செயலில் மருந்து மூலப்பொருள்ப்ரைஸஸ் கட்டுப்பாடு

COVID-19: India s Remdesivir Production Reached 1 2 Crore Vials A Month In June, Says Centre

COVID-19: India s Remdesivir Production Reached 1 2 Crore Vials A Month In June, Says Centre
ndtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ndtv.com Daily Mail and Mail on Sunday newspapers.

Rajya sabhaMansukh mandaviyaDepartment of pharmaceuticalsNational pharmaceuticals pricing authorityUnion healthMinistry of healthCentre remdesivirCentral drugs standard control organisationDepartment of pharmaceuticals doRemdesivir production reachedMonth in juneDrugs controller generalUnion health minister mansukh mandaviyaActive pharmaceutical ingredientFamily welfareRestricted category

India s Remdesivir prod n capacity rises to 122 49 lakh vials per month in June: Govt

India s Remdesivir prod n capacity rises to 122 49 lakh vials per month in June: Govt
deccanchronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from deccanchronicle.com Daily Mail and Mail on Sunday newspapers.

New delhiRajya sabhaMansukh mandaviyaDepartment of pharmaceuticalsNational pharmaceuticals pricing authorityUnion healthMinistry of healthCentral drugs standard control organisationDepartment of pharmaceuticals doUnion health minister mansukh mandaviyaDrugs controller generalActive pharmaceutical ingredientFamily welfareRestricted categoryBuffer stock managementPrices control

Govt caps trade margin at 70% of distributor level prices on five medical devices

Govt caps trade margin at 70% of distributor level prices on five medical devices
domain-b.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from domain-b.com Daily Mail and Mail on Sunday newspapers.

National pharmaceutical pricing agencyPulse oximeterBlood pressure monitoring machineDigital thermometerDrug prices control orderPrices controlEssential commodities actDrug controllersஇரத்தம் ப்ரெஶர் கண்காணிப்பு இயந்திரம்டிஜிட்டல் வெப்பமானிமருந்து ப்ரைஸஸ் கட்டுப்பாடு ஆர்டர்ப்ரைஸஸ் கட்டுப்பாடுஅவசியம் பொருட்கள் நாடகம்மருந்து கட்டுப்படுத்திகள்

Thermometers, BP machines, oximeters set to get cheaper | India News

Representative image (AP) NEW DELHI: The drug price regulator capped the trade margin of five widely-used medical devices, particularly for management of Covid-19, like pulse oximeter, blood pressure monitoring machine, nebulizer, digital thermometer and glucometer at 70%. The move is expected to result in a significant drop in MRP of these products that are in high demand with many Covid patients under home isolation and treatment needing regular monitoring of blood pressure, blood sugar and oxygen level as well as fever, etc. The data collected by the National Pharmaceutical Pricing Authority (NPPA) shows earlier the margins were ranging up to 709% from price to distributor to MRP level.

National pharmaceutical pricing authorityPrices controlTrade margin rationalisationதேசிய மருந்து ப்ரைஸிஂக் அதிகாரம்ப்ரைஸஸ் கட்டுப்பாடு